An introduction to HTA, Early HTA, and patient preference evidence for demonstrating the value of repurposed medicines.

Repurposing has the potential to bring treatments to patients more quickly and efficiently. However, the success of a repurposed medicine depends not only on its clinical effectiveness, but also on demonstrating its value to healthcare decision-makers and ensuring patient access.

Health Technology Assessment (HTA) is the process used to evaluate the value of a health intervention or technology and inform reimbursement and healthcare decision-making.

Join experts from the Syreon Research Institute for an introduction to HTA and Early HTA, and learn how these approaches can support the development, assessment, and value maximisation of repurposed medicines.

The webinar will also explore the role of patient preferences in value assessment, using case studies to showcase the importance of incorporating patient perspectives to strengthen evidence generation and support patient-centred decision-making.

Register for the webinar here!